Cargando…

COVID-19 vaccine effectiveness against symptomatic infection and hospitalisation in Belgium, July 2021 to May 2022

BACKGROUND: The Belgian COVID-19 vaccination campaign aimed to reduce disease spread and severity. AIM: We estimated SARS-CoV-2 variant-specific vaccine effectiveness against symptomatic infection (VEi) and hospitalisation (VEh), given time since vaccination and prior infection. METHODS: Nationwide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Braeye, Toon, van Loenhout, Joris A F, Brondeel, Ruben, Stouten, Veerle, Hubin, Pierre, Billuart, Matthieu, Chung, Pui Yan Jenny, Vandromme, Mathil, Wyndham-Thomas, Chloé, Blot, Koen, Catteau, Lucy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Centre for Disease Prevention and Control (ECDC) 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311948/ https://www.ncbi.nlm.nih.gov/pubmed/37382885 http://dx.doi.org/10.2807/1560-7917.ES.2023.28.26.2200768

Ejemplares similares

Incidence and Risk Factors of COVID-19 Vaccine Breakthrough Infections: A Prospective Cohort Study in Belgium
por: Stouten, Veerle, et al.
Publicado: (2022)

Clinical Severity of SARS-CoV-2 Omicron Variant Compared with Delta among Hospitalized COVID-19 Patients in Belgium during Autumn and Winter Season 2021–2022
por: Van Goethem, Nina, et al.
Publicado: (2022)

Vaccine effectiveness against onward transmission of SARS-CoV2-infection by variant of concern and time since vaccination, Belgian contact tracing, 2021
por: Braeye, Toon, et al.
Publicado: (2022)

Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2021–2022
por: Braeye, Toon, et al.
Publicado: (2023)

Factors underlying COVID-19 booster vaccine uptake among adults in Belgium
por: Vermeiren, Elias, et al.
Publicado: (2023)

Investigating COVID-19 Vaccine Impact on the Risk of Hospitalisation through the Analysis of National Surveillance Data Collected in Belgium
por: Erazo, Diana, et al.
Publicado: (2022)

Severity of infection with the SARS-CoV-2 B.1.1.7 lineage among hospitalized COVID-19 patients in Belgium
por: Van Goethem, Nina, et al.
Publicado: (2022)

Conceptual causal framework to assess the effect of SARS-CoV-2 variants on COVID-19 disease severity among hospitalized patients
por: Van Goethem, Nina, et al.
Publicado: (2021)

Homologous and Heterologous Prime-Boost Vaccination: Impact on Clinical Severity of SARS-CoV-2 Omicron Infection among Hospitalized COVID-19 Patients in Belgium
por: Meurisse, Marjan, et al.
Publicado: (2023)

COVID-19 vaccination uptake in Belgium: socioeconomic and sociodemographic disparities
por: Cavillot, L, et al.
Publicado: (2022)

Un cadre conceptuel pour étudier la relation de causalité entre des variants du SARS-CoV-2 et la sévérité de la COVID-19 chez les patients hospitalisés
por: Van Goethem, N., et al.
Publicado: (2022)

Predicting COVID-19 progression in hospitalized patients in Belgium from a multi-state model
por: Mertens, Elly, et al.
Publicado: (2022)

Association between COVID-19 Primary Vaccination and Severe Disease Caused by SARS-CoV-2 Delta Variant among Hospitalized Patients: A Belgian Retrospective Cohort Study
por: Robalo, Queeny, et al.
Publicado: (2022)

Obstacles in measles elimination: an in-depth description of a measles outbreak in Ghent, Belgium, spring 2011
por: Braeye, Toon, et al.
Publicado: (2013)

Socioeconomic characteristics and COVID-19 infection in Belgium: the mediating role of vaccination
por: Ghattas, J, et al.
Publicado: (2023)

Serial Intervals for SARS-CoV-2 Omicron and Delta Variants, Belgium, November 19–December 31, 2021
por: Kremer, Cécile, et al.
Publicado: (2022)

Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a nationwide observational study of 8075 participants
por: Catteau, Lucy, et al.
Publicado: (2020)

High number of hospitalisations and non-classical presentations: lessons learned from a measles outbreak in 2017, Belgium
por: Cornelissen, L., et al.
Publicado: (2020)

Prioritisation for future surveillance, prevention and control of 98 communicable diseases in Belgium: a 2018 multi-criteria decision analysis study
por: Klamer, Sofieke, et al.
Publicado: (2021)

Stakeholders’ Perception on National Heatwave Plans and Their Local Implementation in Belgium and The Netherlands
por: van Loenhout, Joris Adriaan Frank, et al.
Publicado: (2016)

Vaccine effectiveness against infection and onwards transmission of COVID-19: Analysis of Belgian contact tracing data, January-June 2021
por: Braeye, Toon, et al.
Publicado: (2021)

COVID-19 measures in Belgium: how perception and adherence of the general population differ between time periods
por: van Loenhout, Joris Adriaan Frank, et al.
Publicado: (2022)

Sévérité de l'infection par le variant Delta du SARS-CoV-2 chez les patients hospitalisés en Belgique
por: Meurisse, M., et al.
Publicado: (2022)

Epidemiology of hospital-acquired bloodstream infections in Belgium: a retrospective dynamic cohort study, 2000-2014
por: Blot, Koen, et al.
Publicado: (2015)

COVID-19 contact tracing in Belgium: main indicators and performance, January – September 2021
por: Proesmans, Kristiaan, et al.
Publicado: (2022)

All-cause mortality supports the COVID-19 mortality in Belgium and comparison with major fatal events of the last century
por: Bustos Sierra, Natalia, et al.
Publicado: (2020)

The Relation between Perceived and Actual Understanding and Adherence: Results from a National Survey on COVID-19 Measures in Belgium
por: Vanderplanken, Kirsten, et al.
Publicado: (2021)

Short-term associations between Legionnaires' disease incidence and meteorological variables in Belgium, 2011–2019
por: Braeye, T., et al.
Publicado: (2020)

Reintroduction of the invasive mosquito species Aedes albopictus in Belgium in July 2013
por: Boukraa, Slimane, et al.
Publicado: (2013)

Varicella paediatric hospitalisations in Belgium: a 1-year national survey
por: Blumental, Sophie, et al.
Publicado: (2016)

Rapid establishment of a national surveillance of COVID-19 hospitalizations in Belgium
por: Van Goethem, Nina, et al.
Publicado: (2020)

Influenza versus other respiratory viruses – assessing severity among hospitalised children, Belgium, 2011 to 2020
por: Fischer, Natalie, et al.
Publicado: (2023)

Multivariate phenomenological models for real-time short-term forecasts of hospital capacity for COVID-19 in Belgium from March to June 2020
por: Nguyen, M. H., et al.
Publicado: (2021)

A large community outbreak of gastroenteritis associated with consumption of drinking water contaminated by river water, Belgium, 2010
por: BRAEYE, T., et al.
Publicado: (2015)

Impact of Rotavirus Vaccination on Hospitalisations in Belgium: Comparing Model Predictions with Observed Data
por: Standaert, Baudouin, et al.
Publicado: (2013)

Lessons learned from a textbook outbreak: EHEC-O157:H7 infections associated with the consumption of raw meat products, June 2012, Limburg, Belgium
por: Braeye, Toon, et al.
Publicado: (2014)

Correction to: Rapid establishment of a national surveillance of COVID-19 hospitalizations in Belgium
por: Van Goethem, Nina, et al.
Publicado: (2021)

Incidence estimation from sentinel surveillance data; a simulation study and application to data from the Belgian laboratory sentinel surveillance
por: Braeye, Toon, et al.
Publicado: (2019)

Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up
por: Litzroth, Amber, et al.
Publicado: (2019)

Organizational characteristics: Effect on outcome of ICU COVID-19 patients in Belgium – Authors' reply
por: TACCONE, Fabio Silvio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u4brfjotgku3oludub85cgknij